Accessibility Menu
Acutus Medical logo

Acutus Medical(OTC) AFIB

Market Cap$3.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-100%
5 Year-100%
1 Year-80%
1 Month+0%
$0.00
+0%
+0.00Today
Acutus Medical last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-29
Acutus Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-22
1 month+0%USD 0.002026-06-29
3 month-90%USD 0.002026-04-29
Year to date-50%USD 0.002025-12-31
1 year-80%USD 0.002025-07-29
3 year-99.99%USD 0.692023-07-28
5 year-100%USD 15.402021-07-30
Since inception-100%USD 26.502020-08-06

Acutus Medical Financials at a Glance

Market Cap

$3.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$20.16M

Net Income (TTM)

-$9.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

144.09 (High)

Price

$0.00

Volume

15

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 7, 2026

AFIB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acutus Medical

Acutus Medical, Inc. is a medical device company focused on the treatment of cardiac arrhythmias. The firm specializes in designing, manufacturing, and commercializing innovative tools for catheter-based ablation procedures, addressing various heart rhythm disorders in both domestic and international markets.

Products and Services
  • Innovative access sheaths and transseptal crossing devices
  • Diagnostic and mapping catheters for precise heart mapping
  • Advanced mapping and imaging consoles with supporting software
Growth Outlook
  • Revenue increased to $7.14 million in Q4 2024, up from $5.27 million in Q3 2024
  • Strong demand for catheter-based solutions supports market expansion
  • Investment in R&D aims to enhance product offerings and market reach
Financial Highlights
  • Trailing twelve months (TTM) revenue of $26.2 million reflects growth potential
  • Current ratio of 2.06 indicates strong liquidity position
  • Net income for Q4 2024 was -$1.41 million, showing ongoing operational challenges
Acutus Medical, Inc. operates in a dynamic sector with a focus on innovative solutions for cardiac care. The company's product portfolio is designed to meet the growing demand for effective treatment options for heart rhythm disorders. Recent financial performance indicates a positive trend in revenue, particularly in the last quarter, suggesting potential for continued growth. The strong liquidity position, as indicated by the current ratio, provides a buffer for navigating operational challenges. Overall, Acutus Medical, Inc. presents an intriguing opportunity within the medical device industry, particularly for those interested in advancements in cardiac care technology.
AI Generated • Jul 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

85

CEO

Takeo Mukai, MBA

Website

www.acutusmedical.com

Headquarters

Carlsbad, CA 92008, US

AFIB Financials

Key Financial Metrics (TTM)

Gross Margin

5.03%

Operating Margin

-0.28%

Net Income Margin

-47.36%

Return on Equity

153.11%

Return on Capital

-0.24%

Return on Assets

-33.33%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

29.91M

Volume

15

Avg. Volume

4.80K

Financials (TTM)

Gross Profit

$1.00M

Operating Income

-$57.00K

EBITDA

$2.25M

Operating Cash Flow

-$31.66M

Capital Expenditure

-$112.00K

Free Cash Flow

-$31.77M

Cash & ST Invst.

$14.02M

Total Debt

$35.76M

Acutus Medical Performance Analysis

Acutus Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 17,263,000N/A
20222022-12-31USD 3,031,000-82.4%
20232023-12-31USD 7,164,000136.4%
20242024-12-31USD 20,157,000181.4%
Acutus Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31148.1%
Q22024-06-3013.8%
Q32024-09-3027.6%
Q42024-12-3135.6%
Acutus Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -4.11N/A
20222022-12-31USD -1.39-66.1%
20232023-12-31USD -2.81101.7%
20242024-12-31USD -0.32-88.6%
Acutus Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-3195.3%
Q22024-06-3043.6%
Q32024-09-30-516.9%
Q42024-12-3175.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$7.14M

+194.8%

Gross Profit

$1.01M

-82.1%

Gross Margin

14.08%

N/A

Market Cap

$3.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$35.29

N/A

Employees

85

N/A

Net Income

-$1.41M

+95.8%

EBITDA

$322.00K

-99.0%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$14.02M

-37.4%

Total Debt

$35.76M

-7.1%

Accounts Receivable

$7.88M

-30.6%

Inventory

$1.79M

-58.2%

Long Term Debt

$27.80M

-22.6%

Short Term Debt

$7.96M

+208.4%

Return on Assets

-33.33%

N/A

Return on Invested Capital

-0.35%

N/A

Free Cash Flow

-$4.02M

+76.1%

Operating Cash Flow

-$4.06M

+77.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVLOEvelo Biosciences, Inc.
$0.00+0.00%
ARDSAridis Pharmaceuticals, Inc.
$0.00+0.00%
ICCTiCoreConnect Inc.
$0.00+0.00%
WPHMWinston Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About AFIB

What is the current price of Acutus Medical?

Acutus Medical is trading at $0.00 per share.

What is the 52-week range for Acutus Medical?

Over the past 52 weeks, Acutus Medical has traded between $0.00 and $0.01.

How much debt does Acutus Medical have?

As of the most recent reporting period, Acutus Medical reported total debt of $35.76M.

How much cash does Acutus Medical have on hand?

Acutus Medical reported $14.02M in cash and cash equivalents in its most recent financial results.

What is Acutus Medical’s dividend yield?

Acutus Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services